Lansoprazole

Product Used For Unknown Indication	32.5%
Gastrooesophageal Reflux Disease	15.1%
Drug Use For Unknown Indication	8.9%
Prophylaxis Against Gastrointestinal Ulcer	5.6%
Reflux Oesophagitis	4.6%
Helicobacter Infection	4.4%
Hypertension	4.4%
Thrombosis Prophylaxis	3.2%
Gastric Ulcer	2.7%
Dyspepsia	2.5%
Rheumatoid Arthritis	2.1%
Haematology Test Abnormal	1.9%
Schizophrenia	1.8%
Myocardial Infarction	1.8%
Prophylaxis	1.8%
Angina Pectoris	1.7%
Pain	1.4%
Gastrooesophageal Reflux Prophylaxis	1.3%
Idiopathic Thrombocytopenic Purpura	1.1%
Hiatus Hernia	1.1%

Product Substitution Issue	11.5%
Urticaria	7.5%
Weight Decreased	7.2%
Vomiting	6.8%
Hypomagnesaemia	6.1%
Drug Ineffective	5.9%
Thrombocytopenia	5.9%
Nausea	5.2%
Colitis Microscopic	4.8%
Gastrooesophageal Reflux Disease	4.5%
International Normalised Ratio Increased	4.5%
Rhabdomyolysis	4.3%
Vision Blurred	4.3%
Ventricular Tachycardia	3.8%
Diarrhoea	3.6%
Large Intestinal Ulcer	3.2%
Drug Interaction	2.9%
Renal Failure Acute	2.9%
Hyponatraemia	2.5%
Rash	2.5%

Secondary

Product Used For Unknown Indication	27.3%
Drug Use For Unknown Indication	18.8%
Hypertension	8.3%
Helicobacter Infection	7.1%
Rheumatoid Arthritis	5.5%
Gastrooesophageal Reflux Disease	4.2%
Prophylaxis	3.7%
Gastric Ulcer	3.4%
Pain	2.4%
Adult T-cell Lymphoma/leukaemia	2.4%
Constipation	2.2%
Duodenal Ulcer	1.9%
Pyrexia	1.8%
Ill-defined Disorder	1.7%
Myocardial Infarction	1.7%
Asthma	1.6%
Idiopathic Thrombocytopenic Purpura	1.6%
Osteoporosis	1.5%
Schizophrenia	1.4%
Gastritis	1.3%

Toxic Epidermal Necrolysis	9.6%
Interstitial Lung Disease	9.1%
Colitis Microscopic	8.2%
Ventricular Tachycardia	7.8%
Drug Rash With Eosinophilia And Systemic Symptoms	5.4%
Pyrexia	4.3%
Toxic Skin Eruption	4.3%
Vomiting	4.3%
Stevens-johnson Syndrome	4.2%
Ventricular Septal Defect	4.2%
Weight Decreased	4.2%
Liver Disorder	4.0%
Paraesthesia	4.0%
White Blood Cell Count Increased	4.0%
Colitis Collagenous	3.9%
Hypomagnesaemia	3.9%
Sepsis	3.9%
Rash	3.7%
Liver Function Test Abnormal	3.4%
Renal Failure	3.3%

Concomitant

Product Used For Unknown Indication	27.2%
Drug Use For Unknown Indication	17.9%
Rheumatoid Arthritis	9.8%
Prophylaxis	9.5%
Hypertension	7.4%
Pain	3.7%
Constipation	2.5%
Multiple Myeloma	2.2%
Gastrooesophageal Reflux Disease	2.2%
Depression	2.2%
Diabetes Mellitus	2.2%
Insomnia	1.8%
Aplastic Anaemia	1.7%
Crohn's Disease	1.7%
Osteoporosis	1.6%
Hepatitis C	1.6%
Prophylaxis Against Gastrointestinal Ulcer	1.4%
Infection Prophylaxis	1.3%
Gastritis	1.2%
Atrial Fibrillation	1.1%

Vomiting	13.7%
White Blood Cell Count Decreased	7.7%
Pyrexia	6.6%
Pneumonia	6.1%
Renal Failure Acute	5.6%
Weight Decreased	5.6%
Sepsis	5.0%
Death	4.6%
Rash	4.5%
Pulmonary Embolism	4.3%
Renal Impairment	4.1%
White Blood Cell Count Increased	4.1%
Thrombocytopenia	3.9%
Interstitial Lung Disease	3.8%
Syncope	3.6%
Nausea	3.6%
Urinary Tract Infection	3.6%
Platelet Count Decreased	3.4%
Neutropenia	3.2%
Malaise	3.1%

Interacting

Product Used For Unknown Indication	40.9%
Parkinson's Disease	11.6%
Helicobacter Infection	10.1%
Acute Myeloid Leukaemia	3.6%
Diabetes Mellitus	3.6%
Gastric Ulcer	2.9%
Prophylaxis Against Transplant Rejection	2.9%
Infective Exacerbation Of Chronic Obstructive Airways Disease	2.5%
Back Pain	2.2%
Drug Use For Unknown Indication	2.2%
Insomnia	2.2%
Reflux Oesophagitis	2.2%
Type 2 Diabetes Mellitus	2.2%
Bronchopulmonary Aspergillosis	1.8%
Epilepsy	1.8%
Febrile Neutropenia	1.4%
Gastrooesophageal Reflux Disease	1.4%
Graft Versus Host Disease	1.4%
Hypertension	1.4%
Onychomycosis	1.4%

International Normalised Ratio Increased	18.3%
Drug Interaction	16.7%
Hypoglycaemia	13.3%
Graft Versus Host Disease	6.7%
Nocturia	6.7%
Platelet Count Decreased	6.7%
Nausea	3.3%
Pancreatitis Chronic	3.3%
Renal Failure Acute	3.3%
Sleep Disorder	3.3%
Transient Ischaemic Attack	3.3%
Anuria	1.7%
Arrhythmia	1.7%
Cerebral Infarction	1.7%
Condition Aggravated	1.7%
Dementia	1.7%
Malabsorption	1.7%
Malaise	1.7%
Pulse Absent	1.7%
Respiratory Failure	1.7%